Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer-Reference-Cited by-同舟云学术

Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer

Published:2016-05 Issue:2 Volume:119 Page:312-318
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Chan Emily,Arlinghaus Lori R.,Cardin Dana B.,Goff Laura,Berlin Jordan D.,Parikh Alexander,Abramson Richard G.,Yankeelov Thomas E.,Hiebert Scott,Merchant Nipun,Bhaskara Srividya,Chakravarthy Anuradha Bapsi

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference30 articles.

1. Pancreatic adenocarcinoma;Ryan;N Engl J Med,2014

2. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial;Neoptolemos;JAMA,2010

3. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial;Oettle;JAMA,2013

4. Neoadjuvant therapy for pancreatic cancer;Lowy;J Gastrointest Surg,2008

5. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial;Small;J Clin Oncol,2008

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecular inhibitors: Therapeutic strategies for pancreatic cancer;Drug Discovery Today;2024-07

2. Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy;Oncotarget;2024-06-03

3. Mechanistic Sequence of Histone Deacetylase Inhibitors and Radiation Treatment: An Overview;Pharmaceuticals;2024-05-08

4. Epigenetic regulation in cancer therapy: From mechanisms to clinical advances;MedComm – Oncology;2024-01-04

5. Epigenetic therapeutic strategies in pancreatic cancer;International Review of Cell and Molecular Biology;2024